NASDAQ:SLDB

Solid Biosciences News Headlines

$4.88
-0.33 (-6.33 %)
(As of 04/12/2021 12:00 AM ET)
Add
Compare
Today's Range
$4.85
Now: $4.88
$5.25
50-Day Range
$5.21
MA: $7.20
$10.72
52-Week Range
$1.93
Now: $4.88
$11.58
Volume1.01 million shs
Average Volume1.71 million shs
Market Capitalization$521.56 million
P/E RatioN/A
Dividend YieldN/A
Beta1.1

Headlines

Solid Biosciences (NASDAQ SLDB) News Headlines Today

SourceHeadline
Solid Biosciences (NASDAQ:SLDB) Shares Gap Up to $5.37Solid Biosciences (NASDAQ:SLDB) Shares Gap Up to $5.37
americanbankingnews.com - April 9 at 10:39 AM
 Analysts Expect Solid Biosciences Inc. (NASDAQ:SLDB) Will Post Earnings of -$0.28 Per Share Analysts Expect Solid Biosciences Inc. (NASDAQ:SLDB) Will Post Earnings of -$0.28 Per Share
americanbankingnews.com - April 8 at 4:22 PM
Solid Biosciences (NASDAQ:SLDB) Stock Price Up 7.5%Solid Biosciences (NASDAQ:SLDB) Stock Price Up 7.5%
americanbankingnews.com - April 7 at 11:42 AM
Solid Biosciences and eHealth See Activist ActionSolid Biosciences and eHealth See Activist Action
finance.yahoo.com - March 26 at 9:01 PM
Solid Biosciences to Participate at Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease DaySolid Biosciences to Participate at Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Day
finance.yahoo.com - March 25 at 8:04 AM
Should You Buy Solid Biosciences (SLDB) Ahead of Earnings?Should You Buy Solid Biosciences (SLDB) Ahead of Earnings?
finance.yahoo.com - March 24 at 10:26 AM
Insider Buying: Solid Biosciences Inc. (NASDAQ:SLDB) Director Buys 2,608,695 Shares of StockInsider Buying: Solid Biosciences Inc. (NASDAQ:SLDB) Director Buys 2,608,695 Shares of Stock
americanbankingnews.com - March 23 at 7:38 PM
Solid Biosciences Announces Closing of Public Offering and Full Exercise of Over-Allotment OptionSolid Biosciences Announces Closing of Public Offering and Full Exercise of Over-Allotment Option
finance.yahoo.com - March 23 at 7:21 PM
aTyr Pharma (NASDAQ:LIFE) & Solid Biosciences (NASDAQ:SLDB) Head-To-Head SurveyaTyr Pharma (NASDAQ:LIFE) & Solid Biosciences (NASDAQ:SLDB) Head-To-Head Survey
americanbankingnews.com - March 23 at 6:45 PM
Ra Capital Management, L.P. Buys 2,206,685 Shares of Solid Biosciences Inc. (NASDAQ:SLDB) StockRa Capital Management, L.P. Buys 2,206,685 Shares of Solid Biosciences Inc. (NASDAQ:SLDB) Stock
americanbankingnews.com - March 23 at 4:52 PM
Credit Suisse Group Boosts Solid Biosciences (NASDAQ:SLDB) Price Target to $8.00Credit Suisse Group Boosts Solid Biosciences (NASDAQ:SLDB) Price Target to $8.00
americanbankingnews.com - March 22 at 9:48 AM
SVB Leerink Upgrades Solid Biosciences (NASDAQ:SLDB) to OutperformSVB Leerink Upgrades Solid Biosciences (NASDAQ:SLDB) to Outperform
americanbankingnews.com - March 22 at 9:08 AM
Solid Biosciences Inc. (NASDAQ:SLDB) Given Consensus Recommendation of "Buy" by BrokeragesSolid Biosciences Inc. (NASDAQ:SLDB) Given Consensus Recommendation of "Buy" by Brokerages
americanbankingnews.com - March 22 at 6:29 AM
Solid Biosciences Announces Pricing of Public Offering of Common StockSolid Biosciences Announces Pricing of Public Offering of Common Stock
finance.yahoo.com - March 19 at 7:53 AM
Solid Biosciences Announces Proposed Public Offering of Common StockSolid Biosciences Announces Proposed Public Offering of Common Stock
finance.yahoo.com - March 17 at 5:55 PM
Were Not Very Worried About Solid Biosciences (NASDAQ:SLDB) Cash Burn RateWe're Not Very Worried About Solid Biosciences' (NASDAQ:SLDB) Cash Burn Rate
finance.yahoo.com - March 17 at 12:55 PM
Implied Volatility Surging for Solid Biosciences (SLDB) Stock OptionsImplied Volatility Surging for Solid Biosciences (SLDB) Stock Options
finance.yahoo.com - March 17 at 12:55 PM
Why Solid Biosciences Stock Is Crashing TodayWhy Solid Biosciences Stock Is Crashing Today
finance.yahoo.com - March 16 at 3:19 PM
Solid Bios DMD Gene Therapy Shows Promising Early Data, No New Safety Concerns, But Fails To Cheer InvestorsSolid Bio's DMD Gene Therapy Shows Promising Early Data, No New Safety Concerns, But Fails To Cheer Investors
markets.businessinsider.com - March 16 at 10:19 AM
The Daily Biotech Pulse: Fulgent Nabs CDC Contract, Enzo Rallies, Solid Biosciences Releases Gene Therapy Data, Moderna Begins Pediatric Vaccine StudyThe Daily Biotech Pulse: Fulgent Nabs CDC Contract, Enzo Rallies, Solid Biosciences Releases Gene Therapy Data, Moderna Begins Pediatric Vaccine Study
markets.businessinsider.com - March 16 at 10:19 AM
Solid Biosciences, Inc. to Host Earnings CallSolid Biosciences, Inc. to Host Earnings Call
finance.yahoo.com - March 15 at 6:46 PM
Solid Biosciences Reports Efficacy and Safety Data from the Ongoing IGNITE DMD Clinical Trial and Resumption of Patient Dosing in the 2E14 vg/kg CohortSolid Biosciences Reports Efficacy and Safety Data from the Ongoing IGNITE DMD Clinical Trial and Resumption of Patient Dosing in the 2E14 vg/kg Cohort
finance.yahoo.com - March 15 at 6:46 PM
Solid Biosciences Announces Appointments to Management Team and Board of DirectorsSolid Biosciences Announces Appointments to Management Team and Board of Directors
finance.yahoo.com - March 4 at 9:51 AM
Solid Biosciences Reports Inducement Grant to New Chief Legal OfficerSolid Biosciences Reports Inducement Grant to New Chief Legal Officer
finance.yahoo.com - March 4 at 9:51 AM
Efficacy and Safety Data from Solid Biosciences...Efficacy and Safety Data from Solid Biosciences...
benzinga.com - February 24 at 8:38 PM
Efficacy and Safety Data from Solid Biosciences’ Ongoing IGNITE DMD Phase I/II Clinical Trial to be Presented at the 2021 MDA Clinical & Scientific ConferenceEfficacy and Safety Data from Solid Biosciences’ Ongoing IGNITE DMD Phase I/II Clinical Trial to be Presented at the 2021 MDA Clinical & Scientific Conference
finance.yahoo.com - February 24 at 8:38 PM
Solid Biosciences to Present at Upcoming Investor ConferencesSolid Biosciences to Present at Upcoming Investor Conferences
finance.yahoo.com - February 17 at 12:32 PM
Why Solid Biosciences Stock Is Sinking TodayWhy Solid Biosciences Stock Is Sinking Today
finance.yahoo.com - January 8 at 8:07 PM
Sarepta Stock Dropped 50% After Gene-Therapy Setback. What to Do Now.Sarepta Stock Dropped 50% After Gene-Therapy Setback. What to Do Now.
finance.yahoo.com - January 8 at 8:07 PM
Sarepta Crashes On Mixed Results For Gene Therapy In Muscular DystrophySarepta Crashes On Mixed Results For Gene Therapy In Muscular Dystrophy
finance.yahoo.com - January 7 at 6:53 PM
Solid Biosciences to Present at 39th Annual J.P. Morgan Healthcare ConferenceSolid Biosciences to Present at 39th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 6 at 12:49 PM
RARE Dec 2020 125.000 putRARE Dec 2020 125.000 put
sg.finance.yahoo.com - December 22 at 11:42 PM
Analyzing The Price Action In Solid Biosciences Stock TodayAnalyzing The Price Action In Solid Biosciences Stock Today
benzinga.com - December 15 at 3:19 PM
Is SLDB A Good Stock To Buy Now?Is SLDB A Good Stock To Buy Now?
finance.yahoo.com - December 11 at 4:58 PM
Solid Biosciences Announces $90 Million Private PlacementSolid Biosciences Announces $90 Million Private Placement
finance.yahoo.com - December 11 at 11:58 AM
Are Options Traders Betting on a Big Move in Solid Biosciences (SLDB) Stock?Are Options Traders Betting on a Big Move in Solid Biosciences (SLDB) Stock?
finance.yahoo.com - December 7 at 4:20 PM
Solid Biosciences: Does Not Look Like A Solid Investment Given Its Unsatisfactory Trial DataSolid Biosciences: Does Not Look Like A Solid Investment Given Its Unsatisfactory Trial Data
seekingalpha.com - November 10 at 9:47 AM
Solid Biosciences (SLDB) CEO Ilan Ganot on Q3 2020 Results - Earnings Call TranscriptSolid Biosciences' (SLDB) CEO Ilan Ganot on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 8 at 9:30 AM
Solid Biosciences (SLDB) Reports Wider-Than Expected Q3 LossSolid Biosciences (SLDB) Reports Wider-Than Expected Q3 Loss
nasdaq.com - November 5 at 1:38 PM
Solid Biosciences Reports Third Quarter 2020 Financial Results and Provides Business UpdateSolid Biosciences Reports Third Quarter 2020 Financial Results and Provides Business Update
finance.yahoo.com - November 5 at 8:38 AM
Solid Biosciences to Host Third Quarter 2020 Financial Results and Business Update Call on November 5, 2020Solid Biosciences to Host Third Quarter 2020 Financial Results and Business Update Call on November 5, 2020
benzinga.com - November 3 at 7:40 AM
The Petri Dish: A $295M Duchenne deal, a new biotech CEO and trial failureThe Petri Dish: A $295M Duchenne deal, a new biotech CEO and trial failure
bizjournals.com - October 29 at 12:52 PM
Ultragenyx and Solid Biosciences Announce Strategic Collaboration to Develop and Commercialize New Gene Therapies for Duchenne Muscular DystrophyUltragenyx and Solid Biosciences Announce Strategic Collaboration to Develop and Commercialize New Gene Therapies for Duchenne Muscular Dystrophy
finance.yahoo.com - October 23 at 10:01 AM
Do Options Traders Know Something About Solid Biosciences (SLDB) Stock We Dont?Do Options Traders Know Something About Solid Biosciences (SLDB) Stock We Don't?
nasdaq.com - October 9 at 12:37 PM
Solid Biosciences to Participate in Virtual Fireside Chat at the Chardan 4th Annual Genetic Medicines ConferenceSolid Biosciences to Participate in Virtual Fireside Chat at the Chardan 4th Annual Genetic Medicines Conference
markets.businessinsider.com - October 2 at 8:42 AM
Stock Alert: Solid Biosciences Up 139% As FDA Lifts Hold On TrialStock Alert: Solid Biosciences Up 139% As FDA Lifts Hold On Trial
nasdaq.com - October 1 at 11:55 PM
Chardan raises Solid Biosciences price target 250%Chardan raises Solid Biosciences price target 250%
seekingalpha.com - October 1 at 6:55 PM
Solid Biosciences says FDA lifts halt on gene therapy trial, shares soarSolid Biosciences says FDA lifts halt on gene therapy trial, shares soar
uk.reuters.com - October 1 at 1:43 PM
Mid-Day Market Update: Crude Oil Down 5.5%; Solid Biosciences Shares JumpMid-Day Market Update: Crude Oil Down 5.5%; Solid Biosciences Shares Jump
benzinga.com - October 1 at 1:43 PM
Why Solid Bios Future Just Got a Lot BrighterWhy Solid Bio's Future Just Got a Lot Brighter
msn.com - October 1 at 1:43 PM
This page was last updated on 4/13/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.